Moscow, Russia – March 14th, 2017. Institute for Systems Biology Moscow – a company, providing modeling services for innovative drug design, announced participation in ASCPT 2017 Meeting, which is held on 15-18 March in Washington, DC. ISBM will present several studies and demonstrate an updated version of platform for quantitative systems pharmacology modeling of immune response - Immune Response Template (IRT). Also the ISBM CEO Oleg Demin will take part in the Editorial Board Meeting of the CPT: Pharmacometrics & Systems Pharmacology Journal (Nature Publishing Group).
ISBM is honored for such a great opportunity to share the latest results with colleagues and to show its research integrated in commercial project. On ASCPT2017 Meeting the ISBM team will be focused on the QSP-modeling of immune response. They will present mechanistic approaches for description of the different stages of immune cells lifecycle: maturation, migration, activation and more.
All these theoretical methods were used in the updated platform for “rapid” QSP modeling. With the help of IRT one can create model templates of immune response in a few clicks. This can significantly improve the development of drugs, for example in the field of immuno-oncology.
To learn more about the mechanistic modeling of cell dynamics, to talk with the leading specialists of the Institute for Systems Biology Moscow and to see the possibilities of IRT one can by visiting ISBM stand on March 15-18 from 9 am in Exhibit Hall A / B South, Washington Marriott Wardman Park, Washington, DC, USA.
The poster session materials are shared on the company page http://insysbio.ru/en/publication/materials
| ← | October 2025 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
1.
02 Oct 2025 13:23
InSysBio to announce participation in BioTechX Europe 2025 with focus on AI and QSP
InSysBio announces their participation in BioTechX Europe 2025. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, and Igor Goryanin, Professor at University of Edinburgh, will host a roundtable discussion entitled, "Integrating Artificial Intelligence with Quantitative Systems Pharmacology (QSP): Opportunities and Challenges"
|
3
|
4
|
5
| ||
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
|
13
|
14
|
15
|
16
1.
16 Oct 2025 12:13
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
InSysBio launches a new data annotation service designed to support researchers and analysts who require specific, literature-based biological data to be added to InSysBio’s CYTOCON or fIVE databases for use in QSP modeling, analysis, or decision-making. The new service allows clients to submit targeted data requests related to diseases, tissues, cell types, and cytokines
|
17
|
18
|
19
|
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
|
27
|
28
|
29
1.
29 Oct 2025 15:08
The project aims at mechanistic PK/RO modeling to predict optimal dose and regimen of BGB-B2033, GPC3 x 4-1BB bispecific antibody
InSysBio, one of the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with BeOne Medicines, a global oncology company.
|
30
|
31
| ||